13F Pro

SEC Form 4 reporting owner

Coric Vlad

Coric Vlad has filed 10 Form 4 transactions reported between January 5, 2026 and June 5, 2026, as Director of Royalty Pharma plc, Chief Executive Officer of Biohaven Ltd. and Director of Veradermics, Inc.

Name as filed: Coric Vlad

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
None
reported
Companies
3
with Form 4 filings
Latest transaction
Jun 5, 2026
transaction date

Roles and reported holdings

  • RPRXRoyalty Pharma plc
    Jun 5, 2026

    Director

    No common-stock holding reported on a purchase, sale, gift or withholding line.

  • BHVNBiohaven Ltd.
    Jan 5, 2026 – Feb 27, 2026

    Chief Executive Officer

    Held directly1,803,968 sh as of Jan 5, 2026 · Form 4
  • MANEVeradermics, Inc
    Feb 3, 2026 – Feb 5, 2026

    Director

    No common-stock holding reported on a purchase, sale, gift or withholding line.

    1 line is priced far from MANE’s market price that day, so the filing may concern a different security. Left out of totals and holdings; see the filings.

Transaction history

All 10 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Jun 5, 2026RPRXDirectorGrant or awardCode A · direct4,545—Form 4
Feb 27, 2026BHVNChief Executive OfficerGrant or awardCode A · direct550,000—Form 4
Feb 5, 2026MANEDirectorOpen-market purchaseCode P · indirectPrice far from market; may be another security58,823$1000K@ $17.00Form 4
Feb 5, 2026MANEDirectorConversion of derivativeCode C · direct117,112—Form 4
Feb 5, 2026MANEDirectorConversion of derivativeCode C · indirect78,075—Form 4
Feb 5, 2026MANEDirectorConversion of derivativeCode C · indirect148,794—Form 4
Feb 5, 2026MANEDirectorConversion of derivativeCode C · indirect33,706—Form 4
Feb 3, 2026MANEDirectorGrant or awardCode A · direct51,525—Form 4
Jan 5, 2026BHVNChief Executive OfficerShares withheld for tax or exercise priceCode F · direct7,430$74K@ $9.93Form 4
Jan 5, 2026BHVNChief Executive OfficerOption exerciseCode M · direct14,250—Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

1 open-market line is priced outside 0.67×–1.5× of the stock’s closing price that day. A gap that large usually means the filing reports a different security than the company it is filed under, so those lines are shown but left out of totals and holdings.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.